Androgen receptor signaling and vitamin D receptor action in prostate cancer cells

Shalini Murthy1, Irina U Agoulnik, Nancy L Weigel

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas77030, USA.

The Prostate
|March 9, 2005
PubMed
Abstract

Insights

Vitamin D3 inhibits prostate cancer cell growth, but this effect is partly reversed by anti-androgens in some cell lines. However, vitamin D3 remains effective against most prostate cancers, even with androgen ablation therapy.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • 1,25(OH)2D3 inhibits prostate cancer cell growth.
  • Previous studies suggest 1,25(OH)2D3 actions in LNCaP cells are androgen-dependent.
  • Anti-androgen therapy is used for metastatic prostate cancer.

Purpose of the Study:

  • To assess the requirement for endogenous androgens in 1,25(OH)2D3-mediated growth inhibition of AR+ prostate cancer cell lines.
  • To investigate the mechanism of anti-androgen reversal of 1,25(OH)2D3-dependent growth inhibition in LNCaP cells.

Main Methods:

  • Assessed androgen requirement for 1,25(OH)2D3 growth inhibition in AR+ prostate cancer cell lines.
  • Investigated mechanism of anti-androgen reversal of 1,25(OH)2D3-dependent growth inhibition.
  • Analyzed AS3 (APRIN) gene as a potential common target.

Main Results:

  • 1,25(OH)2D3 inhibited androgen-independent LNCaP cell derivatives, but Casodex reduced this response.
  • AS3 (APRIN), a gene crucial for androgen-dependent growth arrest, is a primary target for both 1,25(OH)2D3 and androgens.
  • Casodex reduced AS3 induction by 1,25(OH)2D3, suggesting a role in the observed effect.
  • Casodex reversal of 1,25(OH)2D3 effects was unique to LNCaP-derived cells.

Conclusions:

  • Anti-androgen reversal of 1,25(OH)2D3-dependent growth inhibition is specific to LNCaP-derived prostate cancer cell lines.
  • 1,25(OH)2D3 strongly inhibits androgen-independent LNCaP cell derivatives.
  • VDR agonist treatment is likely effective in most prostate cancers, irrespective of androgen ablation therapy.

Related Concept Videos

Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).